Blinded independent central review, predefined assessment criteria, and reader qualification processes are non-negotiable for pivotal studies.
Medical imaging guide
Best medical imaging vendor for clinical trials: shortlist for endpoints, quality, and regulatory confidence.
The best medical imaging vendor is the one that delivers clean, auditable image data that regulators trust, with the reader expertise and workflow reliability the endpoint demands.
Protocol-compliant acquisition, site training, and rejection management prevent downstream noise in the data.
Sponsors should verify reader qualifications, inter-reader variability data, and how the vendor handles discordant reads.
Emerging AI tools can improve efficiency but should complement validated reader workflows rather than create untested regulatory paths.
What to test
Ask whether the imaging vendor can demonstrate regulatory-grade endpoint delivery with the specific modality and disease area the study requires.
- Core lab experience with the specific imaging modality and therapeutic indication.
- Reader qualification processes and documented inter-reader variability.
- Regulatory submission experience with imaging endpoints in comparable studies.
Where shortlists fail
Imaging vendor shortlists weaken when sponsors choose based on volume or brand without testing therapeutic specificity and reader quality.
- Choosing a general imaging vendor when the endpoint requires disease-specific reader expertise.
- Underestimating the impact of image acquisition variability on endpoint quality.
- Assuming AI tools reduce the need for experienced readers.
Use CVC
Compare medical imaging vendors with more structure.
Use the vendor directory to build a shortlist, then use sponsor support if the final process needs more pressure-testing.
Related guide
Best central lab for clinical trials
For central laboratory vendor comparison covering specimen management and lab data integration, see the central lab guide.
Read the related guide